Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma

Published:2021-04-08 Issue:11 Volume:12 Page:1668-1672
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Watanabe Kageaki¹,Okuma Yusuke¹²^ORCID,Kawai Shoko¹,Nagamata Makoto³,Hosomi Yukio¹

Affiliation:

1. Department of Thoracic Oncology and Respiratory Medicine Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Bunkyo Japan

2. Department of Thoracic Oncology National Cancer Center Hospital Chuo Japan

3. Nagamata Clinic Kumagaya Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13892

Reference16 articles.

1. Progress in the Management of Malignant Pleural Mesothelioma in 2017

2. Estimation of the global burden of mesothelioma deaths from incomplete national mortality data

3. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

4. Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health;Neumann V;Dtsch Arztebl Int.,2013

5. Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Narrative Nursing Intervention Based on Targeted Nursing Intervention on Anxiety and Nursing Satisfaction of Patients with Malignant Tumors Undergoing Chemotherapy;Journal of Healthcare Engineering;2021-11-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3